Notice of Extension of PAR-13-128 "Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)" to Include One Additional Council Round

Notice Number: NOT-HL-16-297

Key Dates
Release Date: February 3, 2016

Related Announcements
NOT-HL-16-304
NOT-HL-16-303
PAR-13-128

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement PAR-13-128 "Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)" will be extended to include one additional Advisory Council Review - January 2017. This extension thereby permits additional application due dates corresponding to Award Cycle II as follows:

Award Cycle II Application Due Date

R01 June 5, 2016
New

R01 July 5, 2016
Renewal
Resubmission
Revision

AIDS & AIDS-Related Applications September 7, 2016

The Key Dates table is updated accordingly:

Part 1. Overview Information

Key Dates

Posted Date

March 1, 2013

Open Date (Earliest Submission Date)

May 5, 2013

Letter of Intent Due Date(s)

Not Applicable

Application Due Date(s)

Standard dates apply, by 5:00 PM local time of applicant organization.

All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Standard AIDS dates apply, by 5:00 PM local time of applicant organization.

All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

Standard dates apply

Advisory Council Review

Standard dates apply

Earliest Start Date

Standard dates apply

Expiration Date

September 8, 2016

Due Dates for E.O. 12372

Not Applicable

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Keary A. Cope, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0287
Email:copeka@nhlbi.nih.gov